Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 24

1.

Usage patterns of stop smoking medications in Australia, Canada, the United Kingdom, and the United States: findings from the 2006-2008 International Tobacco Control (ITC) Four Country Survey.

Fix BV, Hyland A, Rivard C, McNeill A, Fong GT, Borland R, Hammond D, Cummings KM.

Int J Environ Res Public Health. 2011 Jan;8(1):222-33. doi: 10.3390/ijerph8010222. Epub 2011 Jan 20.

PMID:
21318025
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Nicotine receptor partial agonists for smoking cessation.

Cahill K, Stead LF, Lancaster T.

Cochrane Database Syst Rev. 2011 Feb 16;(2):CD006103. doi: 10.1002/14651858.CD006103.pub5. Review. Update in: Cochrane Database Syst Rev. 2012;4:CD006103.

PMID:
21328282
[PubMed - indexed for MEDLINE]
3.

Nicotine receptor partial agonists for smoking cessation.

Cahill K, Stead LF, Lancaster T.

Cochrane Database Syst Rev. 2010 Dec 8;(12):CD006103. doi: 10.1002/14651858.CD006103.pub4. Review. Update in: Cochrane Database Syst Rev. 2011;(2):CD006103.

PMID:
21154363
[PubMed - indexed for MEDLINE]
4.

Nicotine receptor partial agonists for smoking cessation.

Cahill K, Stead LF, Lancaster T.

Cochrane Database Syst Rev. 2012 Apr 18;4:CD006103. doi: 10.1002/14651858.CD006103.pub6. Review.

PMID:
22513936
[PubMed - indexed for MEDLINE]
5.

Nicotine receptor partial agonists for smoking cessation.

Cahill K, Stead LF, Lancaster T.

Cochrane Database Syst Rev. 2008 Jul 16;(3):CD006103. doi: 10.1002/14651858.CD006103.pub3. Review. Update in: Cochrane Database Syst Rev. 2010;(12):CD006103.

PMID:
18646137
[PubMed - indexed for MEDLINE]
6.

Relapse prevention in UK Stop Smoking Services: current practice, systematic reviews of effectiveness and cost-effectiveness analysis.

Coleman T, Agboola S, Leonardi-Bee J, Taylor M, McEwen A, McNeill A.

Health Technol Assess. 2010 Oct;14(49):1-152, iii-iv. doi: 10.3310/hta14490. Review.

PMID:
21040645
[PubMed - indexed for MEDLINE]
Free Article
7.

Varenicline in the management of smoking cessation: a single technology appraisal.

Hind D, Tappenden P, Peters J, Kenjegalieva K.

Health Technol Assess. 2009 Sep;13 Suppl 2:9-13. doi: 10.3310/hta13suppl2/02. Review.

PMID:
19804684
[PubMed - indexed for MEDLINE]
Free Article
8.

Adverse effects and tolerability of medications for the treatment of tobacco use and dependence.

Hays JT, Ebbert JO.

Drugs. 2010 Dec 24;70(18):2357-72. doi: 10.2165/11538190-000000000-00000. Review.

PMID:
21142259
[PubMed - indexed for MEDLINE]
9.

Varenicline: a pharmacoeconomic review of its use as an aid to smoking cessation.

Keating GM, Lyseng-Williamson KA.

Pharmacoeconomics. 2010;28(3):231-54. doi: 10.2165/11204380-000000000-00000. Review.

PMID:
20108995
[PubMed - indexed for MEDLINE]
10.

Varenicline: a first-line treatment option for smoking cessation.

Garrison GD, Dugan SE.

Clin Ther. 2009 Mar;31(3):463-91. doi: 10.1016/j.clinthera.2009.03.021. Review.

PMID:
19393839
[PubMed - indexed for MEDLINE]
11.

A preliminary benefit-risk assessment of varenicline in smoking cessation.

Cahill K, Stead L, Lancaster T.

Drug Saf. 2009;32(2):119-35. doi: 10.2165/00002018-200932020-00005. Review.

PMID:
19236119
[PubMed - indexed for MEDLINE]
12.

Which is the best primary medication for long-term smoking cessation--nicotine replacement therapy, bupropion or varenicline?

Doggrell SA.

Expert Opin Pharmacother. 2007 Dec;8(17):2903-15. Review.

PMID:
18001252
[PubMed - indexed for MEDLINE]
13.

Nicotine receptor partial agonists for smoking cessation.

Cahill K, Stead LF, Lancaster T.

Cochrane Database Syst Rev. 2007 Jan 24;(1):CD006103. Review. Update in: Cochrane Database Syst Rev. 2008;(3):CD006103.

PMID:
17253581
[PubMed - indexed for MEDLINE]
14.

Varenicline: a selective alpha4beta2 nicotinic acetylcholine receptor partial agonist approved for smoking cessation.

Lam S, Patel PN.

Cardiol Rev. 2007 May-Jun;15(3):154-61. Review.

PMID:
17438382
[PubMed - indexed for MEDLINE]
15.

Interventions for preventing weight gain after smoking cessation.

Farley AC, Hajek P, Lycett D, Aveyard P.

Cochrane Database Syst Rev. 2012 Jan 18;1:CD006219. doi: 10.1002/14651858.CD006219.pub3. Review.

PMID:
22258966
[PubMed - indexed for MEDLINE]
16.

Interventions for smoking cessation and reduction in individuals with schizophrenia.

Tsoi DT, Porwal M, Webster AC.

Cochrane Database Syst Rev. 2013 Feb 28;2:CD007253. doi: 10.1002/14651858.CD007253.pub3. Review.

PMID:
23450574
[PubMed - indexed for MEDLINE]
17.

Varenicline in smoking cessation.

Tonstad S, Rollema H.

Expert Rev Respir Med. 2010 Jun;4(3):291-9. doi: 10.1586/ers.10.27. Review.

PMID:
20524911
[PubMed - indexed for MEDLINE]
18.

Practical implementation of varenicline as an aid to smoking cessation in clinical practice.

Tonstad S.

Pneumologia. 2009 Jul-Sep;58(3):167-74. Review.

PMID:
19817313
[PubMed - indexed for MEDLINE]
19.

Behavioural interventions as adjuncts to pharmacotherapy for smoking cessation.

Stead LF, Lancaster T.

Cochrane Database Syst Rev. 2012 Dec 12;12:CD009670. doi: 10.1002/14651858.CD009670.pub2. Review.

PMID:
23235680
[PubMed - indexed for MEDLINE]
20.

[Effectiveness and safety of varenicline for smoking cessation].

Christalla P, Dewenter M, El-Armouche A.

Dtsch Med Wochenschr. 2012 May;137(18):940-4. doi: 10.1055/s-0032-1304895. Epub 2012 Apr 10. Review. German.

PMID:
22492478
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk